These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18676248)

  • 1. [Guling tablets promotes the proliferation and mineralization and regulates OPG/RANKL/M-CSF expression of osteoblasts via the p38 MAPK pathway in vitro].
    Huang SH; Zhang J; Li J; Cai HB
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1148-50. PubMed ID: 18676248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
    Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
    J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1β-stimulated human SW1353 chondrosarcoma cells.
    Wang Z; Ding L; Zhang S; Jiang T; Yang Y; Li R
    Int J Mol Med; 2014 Dec; 34(6):1720-6. PubMed ID: 25270538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain.
    Kusumi A; Sakaki H; Kusumi T; Oda M; Narita K; Nakagawa H; Kubota K; Satoh H; Kimura H
    J Bone Miner Metab; 2005; 23(5):373-81. PubMed ID: 16133687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
    J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
    Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH
    Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro induction studies of YouGui drink on culture of steroid induced necrosis of femoral head rat osteoblast].
    Tong PJ; Xu L; Hu BS; Jin HT; Li TY; Fang X
    Zhongguo Gu Shang; 2010 Jan; 23(1):23-7. PubMed ID: 20191959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
    Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
    J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of calcitonin on osteoblast cell proliferation and OPG/RANKL expression: experiment with mouse osteoblasts].
    Tian QX; Huang GY; Zhou JL; Liu QH; DU XR
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1501-5. PubMed ID: 17785093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein stimulates osteoblastic differentiation via p38 MAPK-Cbfa1 pathway in bone marrow culture.
    Liao QC; Xiao ZS; Qin YF; Zhou HH
    Acta Pharmacol Sin; 2007 Oct; 28(10):1597-602. PubMed ID: 17883946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts.
    Persson E; Lerner UH
    J Cell Biochem; 2011 Dec; 112(12):3732-41. PubMed ID: 21815197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of parathyroid hormone on osteoprotegerin expression and osteoprotegerin ligand and their related cytokines in human osteoblasts].
    Su X; Liao EY; Peng J; Liu SP; Dai RC
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):562-5. PubMed ID: 16137047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2.
    Tsubaki M; Satou T; Itoh T; Imano M; Yanae M; Kato C; Takagoshi R; Komai M; Nishida S
    Mol Cell Endocrinol; 2012 Sep; 361(1-2):219-31. PubMed ID: 22579611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy.
    Ye M; Zheng J; Chen X; Chen X; Wu X; Lin X; Liu Y
    Mol Med Rep; 2015 Nov; 12(5):7471-8. PubMed ID: 26459042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells].
    Wang BL; Zheng F; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1992-6. PubMed ID: 19062743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of ERK and p38 MAPK pathways on Interleukin-33-induced RANKL expression in osteoblastic cells.
    Mine Y; Makihira S; Yamaguchi Y; Tanaka H; Nikawa H
    Cell Biol Int; 2014 May; 38(5):655-62. PubMed ID: 24448827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IL-17 regulates the expression of RANKL and OPG in human periodontal ligament fibroblasts by activating p38MAPK signaling pathway].
    Nong D; Qin Y; Zhou H; Kang N
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jun; 35(6):545-551. PubMed ID: 31292059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.